Innovative Advances In Prenatal And Newborn Genetic Testing Industry Trends Gaining Momentum in the Global Prenatal And Newborn Genetic Testing Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts

Prenatal And Newborn Genetic Testing Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for prenatal and newborn genetic testing has seen a swift expansion in the recent past. The market value is projected to rise from $6.68 billion in 2024 to $7.61 billion in 2025, implying a compound annual growth rate (CAGR) of 13.9%. Factors responsible for the growth over the historic period include improved procedures for non-invasive prenatal testing, a rise in maternal age, as well as government backing and healthcare policies, coupled with the desire from patients for early detection.

Prenatal And Newborn Genetic Testing Market Size Forecast: What's the Projected Valuation by 2029?
In the coming years, the prenatal and newborn genetic testing market is predicted to experience fast-paced expansion. The market is projected to surge to $12.04 billion in 2029, escalating at a compound annual growth rate (CAGR) of 12.1%. Several factors account for this growth in the forecast period, including wider genetic test panels, increased consciousness about maternal health, guidelines for prenatal and newborn screening, rising emphasis on rare diseases, and ethical and regulatory parameters. Key trends for the forecast period consist of non-invasive prenatal testing (NIPT), whole genome and exome sequencing, the incorporation of artificial intelligence (AI), preimplantation genetic testing (PGT), and direct-to-consumer genetic testing.

View the full report here:
https://www.thebusinessresearchcompany.com/report/prenatal-and-newborn-genetic-testing-global-market-report

What Are the Drivers Transforming the Prenatal And Newborn Genetic Testing Market?
The anticipated growth of prenatal and newborn genetic testing markets is driven by government policies and support for prenatal testing and newborn genetic screening. Government interventions, whether at a local, regional, or national level, aim to tackle specific problems, reach desired objectives, or enhance the quality of life for the populace. In terms of prenatal and newborn genetic testing, these initiatives help detect genetic anomalies in fetuses or newborns, potentially granting them a better chance at life. In a specific case from June 2022, the Australian government dedicated an annual funding of $1.3 million to the New South Wales (NSW) newborn screening program, allowing free testing for the lethal combined immunodeficiency (SCID) and spinal muscular atrophy (SMA). This initiative provides newborn genetic screening to all infants in the state, approximately 100,000 babies annually, potentially saving up to 13 newborns from these severe genetic conditions. Therefore, governmental actions and support in prenatal testing and newborn genetic screening are powerful driving forces of the prenatal and newborn genetic testing markets. Prenatal And Newborn Genetic Testing Market Driver: An Increase in Genetic Disorder Cases Fuels The Growth Of The Prenatal And Newborn Genetic Testing Market

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13158&type=smp

What Long-Term Trends Will Define the Future of the Prenatal And Newborn Genetic Testing Market?
Leading entities in the prenatal and newborn genetic screening markets have prioritized the invention of revolutionary screening tests, which includes noninvasive prenatal tests, making them more accessible and cost-effective while ensuring the provision of dependable services to their consumers. Noninvasive Prenatal Tests (NIPT) or Noninvasive Prenatal Screens (NIPS) are notably state-of-the-art and secure genetic screening methods applied during gestation to gauge the potential risk of specific fetal chromosomal abnormalities. For instance, Juno Diagnostics Inc., an American healthcare technology firm, introduced Juno Hazel, a noninvasive prenatal screening test to identify chromosomal abnormalities and yielding clinical data in November 2022. The test incorporates a sample collection kit, obviating the requirement for phlebotomy, thereby enhancing accessibility. The organization intends to furnish educational materials alongside customized genetic counseling backing by associating with medical practitioners and genetic consultants.

Which Segments in the Prenatal And Newborn Genetic Testing Market Offer the Most Profit Potential?
The prenatal and newborn genetic testing market covered in this report is segmented -

1) By Product Type: Consumables, Instruments
2) By Screening: Non-Invasive Prenatal Testing, Chronic Villus Sampling, Amniocentesis, Maternal Serum Screening, Other Screenings
3) By Disease: Down Syndrome, ket*onuria, Cystic Fibrosis, Sickle Cell Anemia
4) By End User: Hospital, Maternity And Specialty Clinics, Diagnostic Centers

Subsegments:
1) By Consumables: Reagents And Assays, Sample Collection Kits, Test Kits
2) By Instruments: Polymerase Chain Reaction (PCR) Machines, Sequencers, Microarray Analyzers

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13158&type=smp

Which Firms Dominate the Prenatal And Newborn Genetic Testing Market by Market Share and Revenue in 2025?
Major companies operating in the prenatal and newborn genetic testing market report are F. Hoffmann-La Roche AG, Novartis AG, Sanofi S.A., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton, Dickinson and Company, Quest Diagnostic Incorporated, Agilent Technologies Inc., Grifols S.A., Terumo Corporation, Illumina Inc., PerkinElmer Genomics, Quidel Corporation, Bio-Rad Laboratories Inc., Qiagen NV, Werfen S.A., DiaSorin S.p.A, Nova Biomedical, BGI Group, Natera Inc., Trinity Biotech PLC, Meridian Bioscience Inc., Sekisui Diagnostics, Chembio Diagnostics, PTS Diagnostics, Ariosa Diagnostics Inc., AccuBioTech Co. Ltd., Sequenom Inc.

Which Regions Offer the Highest Growth Potential in the Prenatal And Newborn Genetic Testing Market?
North America was the largest region in the prenatal and newborn genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prenatal and newborn genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13158

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.